The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- PMID: 38810185
- PMCID: PMC11323209
- DOI: 10.1056/NEJMoa2312665
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
Abstract
Background: Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening, autosomal recessive syndrome caused by autoimmune regulator (AIRE) deficiency. In APS-1, self-reactive T cells escape thymic negative selection, infiltrate organs, and drive autoimmune injury. The effector mechanisms governing T-cell-mediated damage in APS-1 remain poorly understood.
Methods: We examined whether APS-1 could be classified as a disease mediated by interferon-γ. We first assessed patients with APS-1 who were participating in a prospective natural history study and evaluated mRNA and protein expression in blood and tissues. We then examined the pathogenic role of interferon-γ using Aire-/-Ifng-/- mice and Aire-/- mice treated with the Janus kinase (JAK) inhibitor ruxolitinib. On the basis of our findings, we used ruxolitinib to treat five patients with APS-1 and assessed clinical, immunologic, histologic, transcriptional, and autoantibody responses.
Results: Patients with APS-1 had enhanced interferon-γ responses in blood and in all examined autoimmunity-affected tissues. Aire-/- mice had selectively increased interferon-γ production by T cells and enhanced interferon-γ, phosphorylated signal transducer and activator of transcription 1 (pSTAT1), and CXCL9 signals in multiple organs. Ifng ablation or ruxolitinib-induced JAK-STAT blockade in Aire-/- mice normalized interferon-γ responses and averted T-cell infiltration and damage in organs. Ruxolitinib treatment of five patients with APS-1 led to decreased levels of T-cell-derived interferon-γ, normalized interferon-γ and CXCL9 levels, and remission of alopecia, oral candidiasis, nail dystrophy, gastritis, enteritis, arthritis, Sjögren's-like syndrome, urticaria, and thyroiditis. No serious adverse effects from ruxolitinib were identified in these patients.
Conclusions: Our findings indicate that APS-1, which is caused by AIRE deficiency, is characterized by excessive, multiorgan interferon-γ-mediated responses. JAK inhibition with ruxolitinib in five patients showed promising results. (Funded by the National Institute of Allergy and Infectious Diseases and others.).
Copyright © 2024 Massachusetts Medical Society.
Similar articles
-
JAK Inhibition Immunotherapy for APS-1.N Engl J Med. 2024 May 30;390(20):1918-1921. doi: 10.1056/NEJMe2403419. N Engl J Med. 2024. PMID: 38810191 No abstract available.
-
Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1.J Clin Immunol. 2023 Dec 19;44(1):5. doi: 10.1007/s10875-023-01629-x. J Clin Immunol. 2023. PMID: 38112858 Free PMC article.
-
Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene.J Clin Endocrinol Metab. 2007 Feb;92(2):595-603. doi: 10.1210/jc.2006-1873. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17118990
-
Candidiasis in patients with APS-1: low IL-17, high IFN-γ, or both?Curr Opin Immunol. 2021 Oct;72:318-323. doi: 10.1016/j.coi.2021.08.001. Epub 2021 Aug 26. Curr Opin Immunol. 2021. PMID: 34455138 Free PMC article. Review.
-
AIRE deficiency, from preclinical models to human APECED disease.Dis Model Mech. 2021 Feb 5;14(2):dmm046359. doi: 10.1242/dmm.046359. Dis Model Mech. 2021. PMID: 33729987 Free PMC article. Review.
Cited by
-
Non-canonical IL-22 receptor signaling remodels the mucosal barrier during fungal immunosurveillance.bioRxiv [Preprint]. 2024 Sep 13:2024.09.08.611873. doi: 10.1101/2024.09.08.611873. bioRxiv. 2024. PMID: 39314368 Free PMC article. Preprint.
-
Epithelial responses to fungal pathogens.Curr Opin Microbiol. 2024 Aug;80:102508. doi: 10.1016/j.mib.2024.102508. Epub 2024 Jul 10. Curr Opin Microbiol. 2024. PMID: 38986398 Review.
References
-
- Oftedal BE, Hellesen A, Erichsen MM, et al. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity 2015;42:1185–96. - PubMed
-
- Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322:1829–36. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous